Prim (XMAD:PRM) Issuance of Debt: €0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:PRM Prim SA XMAD:PRM
77 GF Score
Price €13.30
GF Value €7.87
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Prim Issuance of Debt?

Prim XMAD:PRM +1.14% 77 Issuance of Debt is €0.0 Mil as of Dec. 2025. GuruFocus rates XMAD:PRM with a GF Score™ of 77/100 and a GF Value™ of €7.87 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Prim's Issuance of Debt for the six months ended in Dec. 2025 was €0.0 Mil.

Prim's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Prim Issuance of Debt Related Terms

Prim Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Prim's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prim Issuance of Debt Chart

Prim Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.03 2.53 60.13 13.59 0.00

Prim Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XMAD:PRM
77GF Score
Prim SA XMAD:PRM
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prim Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €0.0 Mil mean?
Prim (XMAD:PRM) has a Issuance of Debt of €0.0 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Prim and its competitors.
Is Prim's Issuance of Debt too high?
Prim's current Issuance of Debt is €0.0 Mil. Overall, Prim has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Prim's Issuance of Debt compare to ISRG and BDX?
Prim's Issuance of Debt of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Prim and its competitors. Prim's current Issuance of Debt is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Based on GuruFocus' analysis, Prim (XMAD:PRM) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.87, compared to a current price of €13.30 — trading 69% above its estimated fair value. The current Issuance of Debt is €0.0 Mil. Prim's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Prim (XMAD:PRM), the current Issuance of Debt is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prim (XMAD:PRM) Overvalued in 2026?

Based on GuruFocus' analysis, Prim stock appears to be overvalued. The current stock price of €13.30 is trading 69% above its estimated GF Value™ of €7.87. GuruFocus considers Prim to be Significantly Overvalued.

Key valuation signals for XMAD:PRM:

  • Issuance of Debt: €0.0 Mil
  • GF Value™: €7.87 vs. price of €13.30 (69% above fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the XMAD:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prim Business Description

Other Exchanges 0FP0:UK5P1:Germany
Address Calle F, numero 15, Poligono Industrial 1, Mostoles, Madrid, ESP, 28938
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
77GF Score

Get the complete analysis for XMAD:PRM

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.30
Price
€7.87
GF Value